Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2003
|
| _version_ | 1797104778503782400 |
|---|---|
| author | Demaerschalk, B Silver, B Merino, J Wong, E Hill, MD Poncha, F Foell, B Tamayo, A Buchan, A Hachinski, V |
| author_facet | Demaerschalk, B Silver, B Merino, J Wong, E Hill, MD Poncha, F Foell, B Tamayo, A Buchan, A Hachinski, V |
| author_sort | Demaerschalk, B |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T06:38:19Z |
| format | Conference item |
| id | oxford-uuid:f869c828-5168-44ac-853f-a168e6e2da4e |
| institution | University of Oxford |
| last_indexed | 2024-03-07T06:38:19Z |
| publishDate | 2003 |
| record_format | dspace |
| spelling | oxford-uuid:f869c828-5168-44ac-853f-a168e6e2da4e2022-03-27T12:50:03ZCost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in CanadaConference itemhttp://purl.org/coar/resource_type/c_5794uuid:f869c828-5168-44ac-853f-a168e6e2da4eSymplectic Elements at Oxford2003Demaerschalk, BSilver, BMerino, JWong, EHill, MDPoncha, FFoell, BTamayo, ABuchan, AHachinski, V |
| spellingShingle | Demaerschalk, B Silver, B Merino, J Wong, E Hill, MD Poncha, F Foell, B Tamayo, A Buchan, A Hachinski, V Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada |
| title | Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada |
| title_full | Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada |
| title_fullStr | Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada |
| title_full_unstemmed | Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada |
| title_short | Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada |
| title_sort | cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in canada |
| work_keys_str_mv | AT demaerschalkb costutilityanalysisofintravenoustissueplasminogenactivatorinacuteischemicstrokeincanada AT silverb costutilityanalysisofintravenoustissueplasminogenactivatorinacuteischemicstrokeincanada AT merinoj costutilityanalysisofintravenoustissueplasminogenactivatorinacuteischemicstrokeincanada AT wonge costutilityanalysisofintravenoustissueplasminogenactivatorinacuteischemicstrokeincanada AT hillmd costutilityanalysisofintravenoustissueplasminogenactivatorinacuteischemicstrokeincanada AT ponchaf costutilityanalysisofintravenoustissueplasminogenactivatorinacuteischemicstrokeincanada AT foellb costutilityanalysisofintravenoustissueplasminogenactivatorinacuteischemicstrokeincanada AT tamayoa costutilityanalysisofintravenoustissueplasminogenactivatorinacuteischemicstrokeincanada AT buchana costutilityanalysisofintravenoustissueplasminogenactivatorinacuteischemicstrokeincanada AT hachinskiv costutilityanalysisofintravenoustissueplasminogenactivatorinacuteischemicstrokeincanada |